SOPHARMA AD (23/2023) Invitation and materials for a General shareholders meeting
Report no 23/2023
- 28.04.2023, 16:38
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (22/2023) 2022 Annual Consolidated Financial Report - ESEF format
Report no 22/2023- 28.04.2023, 16:34
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (21/2023) Individual financial report according to IFRS as at 31 March 2023
Report no 21/2023- 27.04.2023, 18:34
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (20/2023) Convening of a General meeting of warrant holders for June 2 2023
Report no 20/2023- 21.04.2023, 14:58
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (19/2023) Sales revenues for March 2023
Report no 19/2023- 20.04.2023, 13:18
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (18/2023) 2022 Annual Individual Financial Report - ESEF format
Report no 18/2023- 29.03.2023, 12:55
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (17/2023) Sales revenues for February 2023
Report no 17/2023- 20.03.2023, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (16/2023) Consolidated financial report according to IFRS as at 31 December 2022
Report no 16/2023- 01.03.2023, 13:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (15/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 17 February 2023.
Report no 15/2023- 21.02.2023, 13:17
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (14/2023) Notification for share participation from "Telso" AD
Report no 14/2023- 21.02.2023, 13:13
- Kategoria: Biznes i finanse
- Źródło: ESPI
